These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11136292)

  • 21. The Effect of Weight and CYP3A5 Genotype on the Population Pharmacokinetics of Tacrolimus in Stable Paediatric Renal Transplant Recipients.
    Prytuła AA; Cransberg K; Bouts AH; van Schaik RH; de Jong H; de Wildt SN; Mathôt RA
    Clin Pharmacokinet; 2016 Sep; 55(9):1129-43. PubMed ID: 27138785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
    Wang DD; Chen X; Li ZP
    J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
    Fukudo M; Yano I; Masuda S; Goto M; Uesugi M; Katsura T; Ogura Y; Oike F; Takada Y; Egawa H; Uemoto S; Inui K
    Clin Pharmacol Ther; 2006 Oct; 80(4):331-45. PubMed ID: 17015051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of sulfonylureas on tacrolimus apparent clearance revealed by a population pharmacokinetics analysis in Chinese adult liver-transplant patients.
    Zhang XQ; Wang ZW; Fan JW; Li YP; Jiao Z; Gao JW; Peng ZH; Liu GL
    Ther Drug Monit; 2012 Apr; 34(2):126-33. PubMed ID: 22377746
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation.
    Staatz CE; Willis C; Taylor PJ; Lynch SV; Tett SE
    Liver Transpl; 2003 Feb; 9(2):130-7. PubMed ID: 12548506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics and pharmacogenetics of tacrolimus in healthy Chinese volunteers.
    Xue L; Zhang H; Ma S; Rui JZ; Miao LY
    Pharmacology; 2011; 88(5-6):288-94. PubMed ID: 22075549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
    Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
    Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients.
    Willis C; Staatz CE; Tett SE
    Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: A model-based meta-analysis approach.
    Nanga TM; Doan TTP; Marquet P; Musuamba FT
    Br J Clin Pharmacol; 2019 Dec; 85(12):2793-2823. PubMed ID: 31471970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of tacrolimus in adult kidney transplant patients: impact of CYP3A5 genotype on starting dose.
    Bergmann TK; Hennig S; Barraclough KA; Isbel NM; Staatz CE
    Ther Drug Monit; 2014 Feb; 36(1):62-70. PubMed ID: 24089074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
    Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
    Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation.
    Han N; Ha S; Yun HY; Kim MG; Min SI; Ha J; Lee JI; Oh JM; Kim IW
    Basic Clin Pharmacol Toxicol; 2014 May; 114(5):400-6. PubMed ID: 24238261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients.
    Chen L; Lu X; Tan G; Zhu L; Liu Y; Li M
    Xenobiotica; 2020 Feb; 50(2):186-191. PubMed ID: 30995884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimation of Tacrolimus Clearance in Saudi Adult Kidney Transplant Recipients.
    Alqahtani S; Alenazi M; Alsultan A; Alsarhani E
    Saudi J Kidney Dis Transpl; 2021; 32(1):101-110. PubMed ID: 34145119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dosing recommendations based on population pharmacokinetics of tacrolimus in Mexican adult patients with kidney transplant.
    Reséndiz-Galván JE; Medellín-Garibay SE; Milán-Segovia RDC; Niño-Moreno PDC; Isordia-Segovia J; Romano-Moreno S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):303-311. PubMed ID: 30260084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.
    Oteo I; Lukas JC; Leal N; Suarez E; Valdivieso A; Gastaca M; Ortiz de Urbina J; Calvo R
    Eur J Clin Pharmacol; 2013 Jan; 69(1):65-74. PubMed ID: 22660442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Population pharmacokinetic models of tacrolimus in paediatric solid organ transplant recipients: A systematic review.
    Khamlek K; Komenkul V; Sriboonruang T; Wattanavijitkul T
    Br J Clin Pharmacol; 2024 Feb; 90(2):406-426. PubMed ID: 37714740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.